449
Participants
Start Date
May 31, 2006
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
Azilsartan Medoxomil
Azilsartan medoxomil 5 mg and comparator matching placebo tablets, orally, once daily for up to 8 weeks.
Azilsartan Medoxomil
Azilsartan medoxomil 10 mg and comparator matching placebo tablets, orally, once daily for up to 8 weeks.
Azilsartan Medoxomil
Azilsartan medoxomil 20 mg and comparator matching placebo tablets, orally, once daily for up to 8 weeks.
Azilsartan Medoxomil
Azilsartan medoxomil 40 mg and comparator matching placebo tablets, orally, once daily for up to 8 weeks.
Azilsartan Medoxomil
Azilsartan medoxomil 80 mg and comparator matching placebo tablets, orally, once daily for up to 8 weeks.
Olmesartan
Olmesartan 20 mg and comparator matching placebo tablets, orally, once daily for up to 8 weeks.
Placebo
Matching placebo tablets, orally, once daily for up to 8 weeks.
Huntsville
Ozark
Mesa
Little Rock
Carmichael
Long Beach
San Diego
Tustin
Denver
Stamford
Trumbull
Waterbury
Hollywood
Jacksonville
Melbourne
Miami
Pembroke Pines
Pinellas Park
Atlanta
Evansville
Shawnee Mission
Auburn
Trenton
Binghamtom
Rochester
Burlington
Charlotte
Concord
Hickory
Salisbury
Winston-Salem
Cincinnati
Columbus
Oklahoma City
Anderson
Mt. Pleasant
Simpsonville
Bristol
Austin
Dallas
Euless
North Richland Hills
San Antonio
Lakewood
Renton
Madison
BA
Córdoba
Ushuaia
Guadalajara, Jal
Mexico City
Monterrey Nuevo Leon
Morelia, Michoacan
Lima
Lead Sponsor
Takeda
INDUSTRY